Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial.

Autor: van de Donk NW; Department of Haematology, VU University Medical Centre, VU University Amsterdam, Amsterdam, Netherlands. Electronic address: n.vandedonk@vumc.nl., van der Holt B; HOVON Data Centre, Department of Haematology, Erasmus Medical Centre Cancer Institute, Erasmus Medical Centre, Rotterdam, Netherlands., Minnema MC; Department of Haematology, UMC Utrecht Cancer Centre, Utrecht, Netherlands., Vellenga E; Department of Haematology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Croockewit S; Department of Haematology, Radboud University Medical Centre, Radboud University Nijmegen, Nijmegen, Netherlands., Kersten MJ; Department of Haematology, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands., von dem Borne PA; Department of Haematology, Leiden University Medical Centre, Leiden University, Leiden, Netherlands., Ypma P; Department of Haematology, Haga Hospital, The Hague, Netherlands., Schaafsma R; Department of Haematology, Medisch Spectrum Twente, Enschede, Netherlands., de Weerdt O; Department of Haematology, St Antonius Hospital, Nieuwegein, Netherlands., Klein SK; Department of Internal Medicine, Meander Medical Centre, Amersfoort, Netherlands., Delforge M; Department of Haematology, University of Leuven, Leuven, Belgium., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands., Bos GM; Department of Haematology, Maastricht University Medical Centre, Maastricht University, Maastricht, Netherlands., Jie KG; Department of Haematology, Zuyderland Medical Centre, Sittard, Netherlands., Sinnige H; Department of Haematology, Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands., Coenen JL; Department of Haematology, Isala, Zwolle, Netherlands., de Waal EG; Department of Haematology, Leeuwarden Medical Centre, Leeuwarden, Netherlands., Zweegman S; Department of Haematology, VU University Medical Centre, VU University Amsterdam, Amsterdam, Netherlands., Sonneveld P; Department of Hematology, Erasmus Medical Centre, Rotterdam, Netherlands., Lokhorst HM; Department of Haematology, VU University Medical Centre, VU University Amsterdam, Amsterdam, Netherlands.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2018 Oct; Vol. 5 (10), pp. e479-e492.

Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands.

Autor: de Waal EG; Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands., Leene M; Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands., Veeger N; Department of Epidemiology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands., Vos HJ; Department of Radiotherapy, Isala Clinics, Zwolle, The Netherlands., Ong F; Department of Radiotherapy, Medical Spectrum Twente, Enschede, The Netherlands., Smit WG; Department of Radiotherapy, Radiotherapeutisch instituut Friesland, Leeuwarden, The Netherlands., Hovenga S; Department of Haematology, Nij Smellinghe Hospital, Drachten, The Netherlands., Hoogendoorn M; Department of Haematology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands., Hogenes M; Laboratory for Pathology East Netherlands Hengelo, Hengelo, The Netherlands., Beijert M; Department of Radiotherapy, University Medical Centre Groningen, Groningen, The Netherlands., Diepstra A; Department of Pathology, University Medical Centre Groningen, Groningen, The Netherlands., Vellenga E; Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands.

Publikováno v: British journal of haematology [Br J Haematol] 2016 Nov; Vol. 175 (4), pp. 661-667. Date of Electronic Publication: 2016 Sep 07.

18F-FDG PET increases visibility of bone lesions in relapsed multiple myeloma: is this hypoxia-driven?

Autor: de Waal EG; From the Departments of *Hematology, †Nuclear Medicine and Molecular Imaging, and ‡Pathology, University Medical Center Groningen, Groningen, the Netherlands., Slart RH, Leene MJ, Kluin PM, Vellenga E

Publikováno v: Clinical nuclear medicine [Clin Nucl Med] 2015 Apr; Vol. 40 (4), pp. 291-6.

Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.

Autor: Bos R, de Waal EG, Kuiper H, Hazenberg BP, Vellenga E

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2011 Oct; Vol. 50 (10), pp. 1925-6. Date of Electronic Publication: 2011 Jun 29.